Hemostasis and Tissue Sealing Agents Market Research Report: by Product (Topical hemostats, Mechanical), End User (Hospital, Ambulatory Centers) - Forecast Till 2030

Hemostasis and Tissue Sealing Agents Market Overview:

The Hemostasis and Tissue Sealing Agents market is projected to reach USD 6442.39 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030. Haemostats, concretes and sealants are useful partners to introduce day medical procedures. Successful haemostats are utilized intraoperatively first and postoperatively to a reduce degree.

These things can be utilized to diffuse unrefined surface passing on, bone biting the dust, spilling over venous sort depletes, and needle-opening kicking the bucket. There has been growing interest for such things as it decreases trouble during medical procedures.

Additionally, gigantic number of medical procedures across the globe are influencing the improvement of the market strongly. Medical procedures are clinical mediations incorporating a cut with instruments generally acted in a functioning theater and normally including different clinical contraptions like catheters and chambers.

For instance, as shown by the Center for Diseases Control and Prevention, around 46.5 million medical procedures are played out reliably in the U.S. Moreover, according to the NHS, operation is the fundamental treatment introduced by the NHS in helper thought inside the UK.

Additionally, in 2015, NHS surveyed that there were around 4.7 million cautious certifications in England, out of which 1.3 million systems were for general an operation and around 1.2 million strategies were for injury and solid wellbeing.

These high medical procedure numbers lead to rising prerequisite for haemostasis and tissue fixing experts which reduces the bet during medical procedures. Regardless, factors, for instance, growing progress irrelevantly prominent methods, nonappearance of reimbursement for these things is hampering the improvement of the market.

Hemostasis and Tissue Sealing Agents Market Segmentation

The hemostasis and tissue sealing agents market has been segmented into product, and end user.

By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.

Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others

The Hemostasis and tissue sealing agents market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The diagnostics imaging workstations market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European Hemostasis and tissue sealing agents market has been segmented into Western Europe and Eastern Europe. The Western Europe diagnostics imaging workstations market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The diagnostics imaging workstations market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The diagnostics imaging services market in the Middle East & Africa has been segmented into the Middle East and Africa.

Hemostasis and Tissue Sealing Agents Market Key players

Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc

Hemostasis and Tissue Sealing Agents Regional Market Summary

Global Hemostasis and tissue sealing agents Systems Share (%), by Region, 2017

Source: White Papers, Company Presentations, Annual Reports

Geographically, the Americas is anticipated to dominate the hemostasis and tissue sealing agents market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. Europe is expected to hold the second largest position in the hemostasis and tissue sealing agents market. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the hemostasis and tissue sealing agents market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

• 
  Topical hemostats
  
  
  
  • Collagen Based Hemostats
  
  
  • Cellulose Based Hemostats
  
  
  • Gelatin Based Hemostats
  
  
  • Polysaccharide Based Hemostats
  
  
  
  




• Active


• Mechanical


• Flowable




• Adhesive & tissue sealant




• Synthetic


• Natural


• Adhesion barrier

• Hospitals


• Ambulatory Centers


• Others

• 
  Americas
  
  
  
  • 
    North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • Latin America
  
  
  
  


• 
  Europe
  
  
  
  • 
    Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  The Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Company Profiles

• Johnson & Johnson


• Cryolife, Inc.


• Baxter International, Inc


• Ethicon LLC


• Integra Lifesciences Corporation


• Becton, Dickinson & Company


• Cohera Medical, Inc.


• Pfizer, Inc


• Medtronic plc


• Braun Melsungen AG


• MIL Laboratories Pvt. Ltd


• Advanced Medical Solutions Group Plc


• Others

In July 2021:

Baxter International Inc. revealed that its Baxter Healthcare Corporation helper had acquired explicit assets of CryoLife's Per Clot Polysaccharide Haemostatic System for up to $60.8 million, thorough of $25 million settled up front. The trade enhanced and extended the affiliation's driving portfolio in crisis facilities, for instance, in the functioning room.

Intended Audience

• Hemostasis and Tissue Sealing Agents manufacturers and suppliers


• Research and Development (R&D) Companies


• Government and Independent Regulatory Authorities


• Market Research and Consulting Usage Modes


• Academic Institutes and Universities